Evidence map›Paper›PMID 30496379›Full record

ReviewEndocrine reviews2019

Ovulation: Parallels With Inflammatory Processes.

Diane M Duffy, CheMyong Ko, Misung Jo, Mats Brannstrom, Thomas E Curry

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Endocrine reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 268 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
268citing papers in PubMed, 1 pooled it
23.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05695352 phase2completednot on this mapstarted 2022, after this paper: background citation

A Phase II Study to Evaluate the Delay in Ovulation Following Oral Levonorgestrel Plus Meloxicam Compared to Placebo in Normal Menstruating Women

TypeinterventionalSponsorInnovaGyn, Inc.Ran2022 to 2025Enrolled19ConditionsPregnancy PreventionArmsLevonorgestrel 1.5mg, Meloxicam 15 mg, Placebo
NCT06306131 phase2completednot on this mapstarted 2023, after this paper: background citation

A Phase II Study to Evaluate the Delay in Ovulation Following Oral Levonorgestrel Plus Meloxicam Compared to Placebo in Obese But Normal Menstruating Women

TypeinterventionalSponsorInnovaGyn, Inc.Ran2023 to 2025Enrolled4ConditionsPregnancy PreventionArmsLevonorgestrel 1.5 milligram, Meloxicam 15 milligram, calcium carbonate 750 milligram
3 · Its place in the literature

Who cites it

268 citing papers in PubMed, 1 synthesis or guideline pooled it, 478 citations in OpenAlex.

  1. Pooled it
  2. Molecular mechanisms of folliculogenesis and oogenesis.Systems biology in reproductive medicine · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

208 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Diane M DuffyDepartment of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia.
CheMyong KoDepartment of Comparative Biosciences, University of Illinois Urbana Champaign, Urbana, Illinois.
Misung JoDepartment of Obstetrics and Gynecology, University of Kentucky, Lexington, Kentucky.
Mats BrannstromDepartment of Obstetrics and Gynecology, University of Gothenburg, Gothenburg, Sweden.
Thomas E CurryDepartment of Obstetrics and Gynecology, University of Kentucky, Lexington, Kentucky.
University of Kentucky · USEastern Virginia Medical School · USStockholm IVF · SEUniversity of Illinois Urbana-Champaign · US

Funding

Ovulation and Luteal Formation in Rodents Monkeys and WomenP01HD071875 · NICHD · UNIVERSITY OF KENTUCKY · PI CURRY, THOMAS E · 2014 to 2018
$6.1M
NICHD NIH HHS P01 HD071875
6 · The paper itself

Abstract

The midcycle surge of LH sets in motion interconnected networks of signaling cascades to bring about rupture of the follicle and release of the oocyte during ovulation. Many mediators of these LH-induced signaling cascades are associated with inflammation, leading to the postulate that ovulation is similar to an inflammatory response. First responders to the LH surge are granulosa and theca cells, which produce steroids, prostaglandins, chemokines, and cytokines, which are also mediators of inflammatory processes. These mediators, in turn, activate both nonimmune ovarian cells as well as resident immune cells within the ovary; additional immune cells are also attracted to the ovary. Collectively, these cells regulate proteolytic pathways to reorganize the follicular stroma, disrupt the granulosa cell basal lamina, and facilitate invasion of vascular endothelial cells. LH-induced mediators initiate cumulus expansion and cumulus oocyte complex detachment, whereas the follicular apex undergoes extensive extracellular matrix remodeling and a loss of the surface epithelium. The remainder of the follicle undergoes rapid angiogenesis and functional differentiation of granulosa and theca cells. Ultimately, these functional and structural changes culminate in follicular rupture and oocyte release. Throughout the ovulatory process, the importance of inflammatory responses is highlighted by the commonalities and similarities between many of these events associated with ovulation and inflammation. However, ovulation includes processes that are distinct from inflammation, such as regulation of steroid action, oocyte maturation, and the eventual release of the oocyte. This review focuses on the commonalities between inflammatory responses and the process of ovulation.

Indexed as

FemaleHumansInflammationLuteinizing HormoneOvulationLuteinizing Hormone

Identifiers

PMID30496379
PMCPMC6405411
OpenAlexW2903464283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.